The European Society of Gastrointestinal Endoscopy (ESGE) and United European
Gastroenterology (UEG) have identified quality of endoscopy as a major priority and we …

OBJECTIVES: Barrett's esophagus (BE) is a common premalignant lesion for which
surveillance is recommended. This strategy is limited by considerable variations in clinical …

Barrett oesophagus (BE), the only known histological precursor of oesophageal
adenocarcinoma (EAC), is a condition in which the squamous epithelium of the oesophagus …

Background & Aims: In view of the mortality and morbidity rates of esophagectomy and the
relatively large group of inoperable patients, local therapeutic techniques are required for …

Objective: Endoscopic therapy is increasingly being used in the treatment of high-grade
intraepithelial neoplasia (HGIN) and mucosal adenocarcinoma (BC) in patients with Barrett's …

BACKGROUND: In view of the increasing incidence of adenocarcinoma in Barrett's
esophagus and the mortality and high morbidity rates associated with surgical therapy for …

Current practices for the management of Barrett's esophagus (BE) vary across Europe, as
several national European guidelines exist. This Position Statement from the European …

Background & Aims Barrett's esophagus–associated high-grade dysplasia is commonly
treated by endoscopy. However, most guidelines offer no recommendations for endoscopic …

ESGE recommends that the evaluation of superficial gastrointestinal (GI) lesions should be
made by an experienced endoscopist, using high definition white-light and …

BACKGROUND & AIMS: Esophageal adenocarcinoma (EA) is increasingly common among
patients with Barrett's esophagus (BE). We aimed to provide consensus recommendations …